Which hedge funds own RNTX? REIN THERAPEUTICS INC, Q2 2026 13F holders
5 of the hedge funds tracked by WhaleCreep disclosed a position in RNTX (REIN THERAPEUTICS INC) in their Q2 2026 13F filings, worth $8.2m in total. The largest holder by portfolio weight is Voss Capital at 0.3% of its book. 1 manager opened a new position this quarter: Citadel Advisors.
5tracked managers holding
1opened this quarter
0exited this quarter
Which hedge funds hold RNTX? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Voss Capital | Q2 2026 | 0.3% | $5.5m | 5,261,921 | 20% | added |
| Palogic Value Management | Q2 2026 | 0.1% | $187.2k | 180,000 | 0% | held |
| Citadel Advisors | Q2 2026 | 0.0% | $2.5m | 2,438,711 | – | new |
| Ancora Advisors | Q2 2026 | 0.0% | $31.2k | 30,000 | 50% | added |
| Renaissance Technologies LLC | Q2 2026 | 0.0% | $19.8k | 19,000 | -22% | reduced |
How has hedge fund ownership of RNTX changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 5 | $8.2m |
| Q1 2026 | 4 | $6.0m |
| Q4 2025 | 3 | $5.0m |
| Q3 2025 | 2 | $3.1m |
| Q2 2025 | 1 | $2.0m |
| Q1 2025 | 1 | $1.8m |
| Q4 2024 | 1 | $2.2m |
| Q3 2024 | 1 | $46.6k |
| Q2 2024 | 1 | $68.9k |
| Q1 2024 | 1 | $299.0k |
| Q4 2023 | 1 | $85.0k |
| Q3 2023 | 1 | $29.0k |
| Q2 2023 | 1 | $28.0k |
| Q1 2023 | 1 | $16.0k |
| Q4 2022 | 1 | $25.0k |
Counts every tracked manager that disclosed RNTX in that quarter's filing, including managers that have since stopped filing.